Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 22.5 mg for 3-month administration, Rx only, Manufactured for: AbbVie Inc., North Chicago, IL 60064; by: Takeda Pharmaceutical Company Limited, Osaka, Japan 540-8645; NDC 0074-3346-03, UPC 3 00743 34603 9.
Published May 7, 2014 · Recall initiated: March 10, 2014
Summary
FDA records drug Class II recall D-1287-2014, published May 7, 2014 and initiated March 10, 2014. Recalling firm: AbbVie Inc; Status: Terminated; Reported quantity: 7362 kits; Lot: Lot #: 1014204, Exp 10/11/15; 1014485, Exp 12/11/16; and 1015007, Exp 12/06/16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
What to do
Voluntary: Firm initiated · Letter
Get an email if LUPRON DEPOT has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LUPRON DEPOT
- Manufacturer
- AbbVie Inc
- Distributor
- Nationwide and Puerto Rico
- UPC
- 300743346039
- Lot
- Lot #: 1014204, Exp 10/11/15; 1014485, Exp 12/11/16; and 1015007, Exp 12/06/16
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilledMay 7, 2014
- FDALupron Depot (leuprolide acetate for depot suspension) Single Dose Administration Kit with prefilledMay 7, 2014
- FDALupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilledMay 7, 2014
- FDAMaximum Strength/Non-Drowsy Tussin DM Adult Maximum Strength, Cough Cold, Dextromethorphan HBr, USP, 10 mgMay 7, 2014
- FDAGlytone Acne, acne treatment facial cleanser, 2% Salicylic Acid, 200 mL/6.7 FL Oz Bottle, Distributed byMay 7, 2014
- FDALUPRON DEPOT-PED (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilledMay 7, 2014
Questions about this recall
Was Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 22.5 mg for 3-month administration, Rx only, Manufactured for: AbbVie Inc., North Chicago, IL 60064; by: Takeda Pharmaceutical Company Limited, Osaka, Japan 540-8645; NDC 0074-3346-03, UPC 3 00743 34603 9. recalled?
Yes. FDA published recall D-1287-2014 on May 7, 2014. Reported hazard: Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LUPRON DEPOT. UPC: 300743346039.